http://ift.tt/hZ0OVi
MIT Technology Review reports that a brain computer interface chip control the patient’s actual arm with a system called functionalelectrical stimulation (FES). This will send signals to as many as 18 arm and hand muscles to allow the subject, who is paralyzed from the neck down, to perform tasks such as eating and nose-scratching.
“This will be the first time someone has hooked up a BCI to an FES device,” says Daniel Moran, a neuroscientist at Washington University at St. Louis who is not involved in the study. “They’re putting the whole system together.” The surgery may occur this or next year, according to Case Western researchers.
Beginning in mid 2008, with the agreement of Cyberkinetics, a new, fully academically-based IDE [Investigational device exemption (IDE)] application (for the “BrainGate2 Neural Interface System”) was developed to continue this important research. In May 2009, the FDA provided a new IDE for the BrainGate2 pilot clinical trial. [Caution: Investigational Device. Limited by Federal Law to Investigational Use.] The BrainGate2 pilot clinical trial is directed by faculty in the Department of Neurology at Massachusetts General Hospital, a teaching affiliate of Harvard Medical School; the research is performed in close scientific collaboration with Brown University’s Department of Neuroscience, School of Engineering, and Brown Institute for Brain Sciences, and the Rehabilitation Research and Development Service of the U.S. Department of Veteran’s Affairs at the Providence VA Medical Center. Additionally, in late 2011, Stanford University joined the BrainGate Research Team as a clinical site and is currently enrolling participants in the clinical trial. This interdisciplinary research team includes scientific partners from the Functional Electrical Stimulation Center at Case Western Reserve University and the Cleveland VA Medical Center. As was true of the decades of fundamental, preclinical research that provided the basis for the recent clinical studies, funding for BrainGate research is now entirely from federal and philanthropic sources.
Read more »
Reposted via Next Big Future
MIT Technology Review reports that a brain computer interface chip control the patient’s actual arm with a system called functionalelectrical stimulation (FES). This will send signals to as many as 18 arm and hand muscles to allow the subject, who is paralyzed from the neck down, to perform tasks such as eating and nose-scratching.
“This will be the first time someone has hooked up a BCI to an FES device,” says Daniel Moran, a neuroscientist at Washington University at St. Louis who is not involved in the study. “They’re putting the whole system together.” The surgery may occur this or next year, according to Case Western researchers.
Beginning in mid 2008, with the agreement of Cyberkinetics, a new, fully academically-based IDE [Investigational device exemption (IDE)] application (for the “BrainGate2 Neural Interface System”) was developed to continue this important research. In May 2009, the FDA provided a new IDE for the BrainGate2 pilot clinical trial. [Caution: Investigational Device. Limited by Federal Law to Investigational Use.] The BrainGate2 pilot clinical trial is directed by faculty in the Department of Neurology at Massachusetts General Hospital, a teaching affiliate of Harvard Medical School; the research is performed in close scientific collaboration with Brown University’s Department of Neuroscience, School of Engineering, and Brown Institute for Brain Sciences, and the Rehabilitation Research and Development Service of the U.S. Department of Veteran’s Affairs at the Providence VA Medical Center. Additionally, in late 2011, Stanford University joined the BrainGate Research Team as a clinical site and is currently enrolling participants in the clinical trial. This interdisciplinary research team includes scientific partners from the Functional Electrical Stimulation Center at Case Western Reserve University and the Cleveland VA Medical Center. As was true of the decades of fundamental, preclinical research that provided the basis for the recent clinical studies, funding for BrainGate research is now entirely from federal and philanthropic sources.
Read more »
Reposted via Next Big Future
No comments:
Post a Comment